Atherosclerosis and arteriosclerosis in chronic renal failure

Kidney International

Volumn 51, Issue 6, 1997, Pages 1678-1695

  London, G M ^a   Drueke, T B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030967042     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.233     Document Type: Editorial

References (196)

1. A.E.G. Raine R. Margreiter F.P. Brunner J.H.H. Ehrich W. Geelings P. Landais C. Loirat N.P. Mallick N.H. Selwood G. Tufveson F. Valderrabano Report on the management of renal failure in Europe, XXII, 1991 Nephrol Dial Transplant Suppl 2 1992 7 35
2. A. Lindner B. Charra D.J. Sherrard B.H. Sribner Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697 701
3. W.W. Nichols M.F. O'Rourke Vascular impedance E. Arnold McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles 1991 Great Britain London 276 278
4. E.J. Krooker E.H. Wood Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man Circ Res 3 1955 623 632
5. L. Gould Physiological basis for assessing critical coronary stenosis Am J Cardiol 33 1976 87 94
6. S. Glagov C. Zarins D.P. Giddens D.N. Ku Hemodynamics and atherosclerosis: Insights and perspectives gained from the studies of human arteries Arch Pathol Lab Med 112 1988 1018 1031
7. S. Glagov E. Weisenberg C. Zarins R. Stankunavicius G.J. Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371 1375
8. D.L. Fry Acute vascular endothelial changes associated with increased blood flow velocity gradients Circ Res 22 1968 165 197
9. 14C-4-cholesterol between serum and wall in the perfused dog common carotid artery Circ Res 32 1973 187 205
10. S. Glagov C. Zarins Is intimal hyperplasia an adaptive response or a pathologic process? Observations on the nature of nonatherosclerotic intimal thickening J Vasc Surg 10 1989 571 573
11. M. O'Rourke Mechanical principles in arterial disease Hypertension 26 1995 2 9
12. J.P. Murgo N. Westerhof J.P. Giolma S.A. Altobelli Aortic input impedance in normal man: Relationship to pressure wave forms Circulation 62 1980 105 116
13. M. O'Rourke Vascular impedance: The relationship between pressure and flow Arterial Function in Health and Disease 1982 Churchill Livingstone Edinburgh 94 132 and pp 185—243
14. G.D. Buckberg B. Towers D.E. Paglia D.G. Mulder J.V. Maloney Subendocardial ischemia after cardiopulmonary bypass J Thorac Cardiovasc Surg 64 1972 669 687
15. H. Watanabe S. Ohtsuka M. Kakihana Y. Sugishita Coronary circulation in dogs with an experimental decrease in aortic compliance J Am Coll Cardiol 21 1993 1497 1506
16. E.G. Lowrie E.G. Lazarus C.L. Hampers J.P. Merrill Cardiovascular disease in dialysis patients N Engl J Med 290 1974 737 738
17. E.G. Lazarus E.G. Lowrie C.L. Hampers J.P. Merrill Cardiovascular disease in uremic patients on hemodialysis Kidney Int 7 Suppl 1975 S167 S175
18. F.P. Brunner R. Brynger C. Chantler R.A. Donckerwolcke R.A. Hathaway C. Jacobs N.H. Selwood A.J. Wing Combined report on regular dialysis and transplantation in Europe Proc EDTA 16 1978 3 82
19. A.J. Nicholls N. Edward G.R.D. Catto J. Engeset M. MacLeod Accelerated arteriosclerosis in long-term dialysis and transplant patients: Fact of fiction Lancet 1 1980 276 278
20. S.G. Rostand J.C. Gretes K.A. Kirk E.A. Rutsky T.E. Andreoli Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis Kidney Int 16 1979 600 611
21. S.G. Rostand K.A. Kirk E.A. Rutsky Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease Kidney Int 22 1982 304 308
22. Renaldatasystem US Annual data report. Survival probabilities and causes of death Am J Kidney Dis 18 Suppl 2 1991 49 60
23. K. Iseki K. Kinjo Y. Kimura A. Osawa K. Fukiyama Evidence of high risk of cerebral hemorrhage in chronic dialysis patients Kidney Int 44 1993 1086 1090
24. J.H. Brown L.P. Hunt N.P. Vites C.D. Short R. Gokal N.P. Mallick Comparative mortality from cardiovascular disease in patients with chronic renal failure Nephrol Dial Transplant 9 1994 1136 1142
25. P.S. Parfrey S.M. Griffiths J.D. Harnett G.M. Kent D. Murray P.E. Barre Outcome and risk factors of ischemic heart disease in chronic uremia Kidney Int 49 1996 1428 1434
26. E. Ritz R. Deppisch E. Stier G. Hänsch Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility Nephrol Dial Transplant 9 Suppl 2 1994 165 172
27. S.G. Rostand J.D. Brunzell R.O. Cannon R.G. Victor Cardiovascular complications in renal failure J Am Soc Nephrol 2 1991 1053 1062
28. W.E. Bloembergen F.K. Port E.A. Mauger R.A. Wolfe Causes of death in dialysis patients: Racial and gender differences J Am Soc Nephrol 5 1994 1231 1242
29. N. Mazzuchi Registro Latinamericano de Dialisis y Trasplante Renal 1995 Montevideo, Uruguay Comite de Registro 1 85 Informe del año 1993
30. T. Kawagishi Y. Nishizawa T. Konishi K. Kawasaki M. Emoto T. Shoji T. Tabata T. Inoue H. Morii High-resolution ultrasonography in evaluation of atherosclerosis in uremia Kidney Int 48 1995 820 826
31. USRDS Annual Data Report. VII. Causes of death Am J Kidney Dis 24 Suppl 2 1996 S88 S95
32. J.D. Harnett G.M. Kent P.E. Barre R. Taylor P.S. Parfrey Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients J Am Soc Nephrol 4 1994 1486 1490
33. G.M. London S.J. Marchais A.P. Guérin F. Fabiani F. Metivier Cardiovascular function in hemodialysis patients Adv Nephrol 20 1991 249 273
34. L.S. Ibels A.C. Alfrey W.E. Hufer P.W. Craswell J.T. Anderson R. Weil Arterial calcification and pathology in uremic patients undergoing dialysis Am J Med 66 1979 790 796
35. J.F. Burke G.C. Francos L.L. Moore S.Y. Cho N. Lasker Accelerated atherosclerosis in chronic dialysis patients—Another look Nephron 21 1978 181 185
36. A.P. Lundin G.A. Friedman Vascular consequences of maintenance hemodialysis–An unproven case Nephron 21 1978 177 180
37. E. Ritz U. Querfeld Atherogenesis—Is it accelerated in uremia Semin Dial 2 1989 252 256
38. J. Batellier M. Wassef R. Merval M. Duriez A. Tedgui Protection from atherosclerosis in vein grafts by rigid external support Arterioscler Thromb 13 1993 379 374
39. R. Collins R. Peto S. MacMahon Antihypertensive therapy: Effects on stroke and coronary heart disease J.D. Swales Textbook of Hypertension 1994 Blackwell Scientific Oxford 1156 1164
40. F.C. Luft Treatment and prevention of hypertension: Where have we been and where are we going Kidney Int 48 Suppl 50 1995 S14 S18
41. A.J. Luik D.G. Struijk U. Gladziwa R.W. van Olden J.P. van Hooff P.W.D. Leeuw K.M.L. Leunissen Diurnal blood-pressure variations in haemodialysis and CAPD patients Nephrol Dial Transplant 9 1994 1616 1621
42. J. Bachmann M. Tepel H. Raidt R. Riezler U. Graefe K. Langer W. Zidek Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients J Am Soc Nephrol 6 1995 121 125
43. F. Vincenti W.J. Amend J. Abele N.J. Feduska O. Salvatierrajr The role of hypertension in hemodialysis-associated atherosclerosis Am J Med 68 1980 363 369
44. G. Piccoli F. Bonello M. Salomone R. Boero G.B. Piccoli R. Bergia G.P. Segoloni F. Quarello Epidemiology of arterial blood pressure and hypertension in maintenance hemodialysis IXth Symposium Gambro, “La Pression Arténelle chez I'Urémique,” 1988 177 183
45. P. Simon K.S. Ang A. Benziane Hypertension artérielle systolique isolée chez l'urémique chronique hémodialysé Arch Mal Coeur 84 1991 1205 1210
46. G.M. London A.P. Guérin B. Pannier S.J. Marchais A. Benetos M.E. Safar Increased systolic pressure in chronic uremia: Role of arterial wave reflections Hypertension 20 1992 10 19
47. B. Darne X. Girerd M. Safar F. Cambien L. Guize B. Darne X. Girerd M. Safar F. Cambien L. Guize Pulsatile versus steady component of blood pressure: A cross-sectional and prospective analysis of cardiovascular mortality Hypertension 13 1989 392 400
48. S. Madhavan W.L. Ooi H. Cohen M.H. Alderman Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction Hypertension 23 1994 395 401
49. B. Lacour T. Drüeke Lipid metabolism S.G. Massry R.C. Glassock Textbook of Nephrology 1995 Williams and Wilkins Baltimore 1395 1404
50. P.O. Attman Hyperlipoproteinemia in renal failure: Pathogenesis and perspectives for intervention Nephrol Dial Transplant 8 1993 294 295
51. Z.A. Massy P. Jungers J.-B. Roullet T. Drüeke B. Lacour Disturbances of apolipoprotein distribution in lipoproteins of uremic patients J Nephrol 6 1993 153 158
52. D. Parsy M. Dracon C. Cachera H.J. Parra G. Vanhoutte A. Tacquet J.C. Fruchart Lipoprotein abnormalities in chronic haemodialysis patients Nephrol Dial Transplant 3 1988 51 56
53. H.N. Hodis W.J. Mack S.P. Azen P. Alaupovic J.M. Pogoda L. Labree L. Cashin-Hemphill D.M. Kramsch D.H. Blankenhorn Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin Circulation 90 1994 42 49
54. P. Alaupovic C. Knight-Gibson H.N. Hodis W.J. Mack L. Cashin-Hemphill D.H. Blankenhorn Effect of apo-B containing lipoprotein particles on the progression of atherosclerotic lesions in the Monitored Atherosclerosis Study (MARS) Atherosclerosis 109 1994 154 (abstract)
55. S.L. Hsia G.O. Perez A.J. Mendez J. Schiffman S. Fletcher J.B. Stoudemire Defect in cholesterol transport in patients receiving maintenance hemodialysis J Lab Clin Med 106 1985 53 61
56. H. Dieplinger P.Y. Schonfeld C.J. Fielding Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis J Clin Invest 77 1986 1071 1083
57. R. McLeod C.E. Reeve J. Frohlich Plasma lipoproteins and lecithinxholesterol acyltransferase distribution in patients on dialysis Kidney Int 25 1984 683 688
58. A.J. Mendez G.O. Perez S.L. Hsia Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: Increased inhibitor activity for cholesteryl ester transfer J Lab Clin Med 111 1988 677 683
59. R.J. Portman R.C. Scott D.D. Rogers D.S. Loose-Mitchell J.M. Lemire R.B. Weinberg Decreased low-density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients Kidney Int 42 1992 1238 1246
60. M. Toborek T. Wasik M. Drozdz M. Klin K. Magner-Wrobel E. Kopieczna-Grzebieniak Effect of hemodialysis on lipid peroxidation and anti-oxidant system in patients with chronic renal failure Metabolism 41 1992 1229 1232
61. J.L. Paul N.D. Sall T. Soni J.L. Poignet A. Lindenbaum N.K. Man N. Moatti D. Raichvarg Lipid peroxidation abnormalities in hemodialyzed patients Nephron 64 1993 106 109
62. W.H. Daerr E.T.E. Windler H. Greten Peroxidative modification of very-low-density lipoproteins in chronic hemodialysis patients Nephron 63 1993 230 231
63. E. Maggi R. Bellazzi F. Falaschi A. Frattoni G. Perani G. Finardi A. Gazo M. Nai D. Romanini G. Bellomo Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis Kidney Int 45 1994 876 883
64. S. Hörkkö M.J. Savolainen K. Kervinen Y.A. Kesäniemi Carbamylation-induced alterations in low-density lipoprotein metabolism Kidney Int 41 1992 1175 1181
65. R. Bucala Z. Makita G. Vega S. Grundy T. Koschinsky A. Cerami H. Vlassara Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci USA 91 1994 9441 9445
66. V. Witko-Sarsat M. Freidlander C. Capeillèfre-Blandin T. Nguyen-Khoa A. Thunguyen J. Zingraff P. Jungers B. Descamps-Latscha Advanced oxidation protein products as a novel marker of oxydative stress in uremia Kidney Int 49 1996 1304 1313
67. L.J. Hazell L. Arnold D. Flowers G. Waeg E. Malle R. Stocker Presence of hypochlorite-modified proteins in human atherosclerotic lesions J Clin Invest 97 1996 1535 1544
68. W. Palinski V. Ord A.S. Plump J.L. Breslow D. Steinberg J.L. Witztum ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malonaldehyde-lysine in serum Arterioscler Thromb 14 1994 605 616
69. L.M. Hulten H. Lindmark U. Diczfalusy I. Björkhem M. Ottosson Y. Liu G. Bondjers O. Wiklund Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages J Clin Invest 97 1996 461 468
70. J.T. Salonen S. Ylä-Herttuala R. Yamamoto S. Butler H. Korpela R. Salonen K. Nyyssönen W. Palinski J.L. Witztum Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
71. C. Bergmark R. Wu U.D. Faire A.K. Lefvert J. Swedenborg Patients with earl-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL Artenoscler Thromb Vase Biol 15 1995 441 445
72. W. Palinski S. Hörkkö E. Miller U.P. Steinbrecher H.C. Powell L.K. Curtiss J.L. Witztum Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice J Clin Invest 98 1996 800 814
73. M. Ando I. Lundkvist J. Bergström B. Lindholm Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients Kidney Int 49 1996 773 780
74. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795
75. A.M. Schmidt O. Hori J.X. Chen J.F. Li J. Crandall J. Zhang R. Cao S.D. Yan J. Brett D. Stern Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice J Clin Invest 96 1995 1395 1403
76. J. Greten I. Kreis K. Wiesel E. Stier A.M. Schmidt D.M. Stern E. Ritz R. Waldherr P.P. Nawroth Receptors for advanced glycation end-products (AGE)—Expression by endothelial cells in non-diabetic uraemic patients Nephrol Dial Transplant 11 1996 786 790
77. R. Hahn K. Oette H. Mondorf K. Finke H.G. Sieberth Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias Atherosclerosis 48 1983 279 288
78. D.H. Blankenhorn P. Alaupovic E. Wickham H.P. Chin S.P. Azen Prediction of angiographic changes in native human coronary arteries and aorto-coronary bypass grafts: Lipid and non-lipid factors Circulation 81 1990 470 476
79. S.B. Hulley R.H. Rosenman R.D. Bawold R.J. Brand Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease N Engl J Med 302 1980 1383 1389
80. R. Tatami H. Mabuchi K. Ueda Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease Circulation 64 1981 1174 1184
81. P.O. Attman P. Alaupovic Lipid and apolipoprotein profiles of uremic dyslipoproteinemia. Relation to renal function and dialysis Nephron 57 1993 401 410
82. L. Burdick M. Periti A. Salvaggio S. Bertoli R. Mangiarotti D. Castagnone G. Anguissola Relation between carotid artery atherosclerosis and time on dialysis. A non-invasive study Clin Nephrol 42 1994 121 126
83. F. Kronenberg H. Kathrein P. König U. Neyer W. Sturm K. Lhotta E. Gröchenig G. Utermann H. Dieplinger Apoli-poprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease Artenoscler Thromb 14 1994 1405 1411
84. E. Ritz P. Vallance M. Nowicki The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-arginine the answer Nephrol Dial Transplant 9 1994 129 130
85. F. Kronenberg Lipoprotein(a) in renal disease: What we have, what we need, what we can forget Nephrol Dial Transplant 10 1995 766 769
86. E. Haber Angiotensin-converting enzyme and lipoprotein(a) as risk factors for myocardial infarction Circulation 91 1995 1888 1890
87. M.J. Callow J. Verstuyft R. Tangirala W. Palinski E.M. Rubin Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a) J Clin Invest 96 1995 1639 1646
88. C. Sandholzer N. Saha J.D. Kark Apo(a) isoforms predict the risk for coronary heart disease: A study in six populations Artenoscler Thromb 12 1992 1214 1226
89. A. Kandoussi C. Cachera D. Pagniez M. Dracon J.C. Fruchart A. Tacquet Plasma level of lipoprotein Lp(a) is high in predialysis and hemodialysis, but not in CAPD Kidney Int 42 1992 424 425
90. M.D. Cressman R.J. Heyka E.P. Paganini J. O'Neil J.I. Skibinski H.F. Hoff Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients Circulation 86 1992 475 482
91. T. Shoji Y. Nishizawa H. Nishitani M. Yamakawa H. Morii High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis Clin Nephrol 38 1992 271 276
92. H. Dieplinger C. Lackner F. Kronenberg C. Sandholzer K. Lhotta F. Hoppichler H. Graf P. König Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipopro-tein(a) J Clin Invest 91 1993 397 401
93. Z.A. Massy C.A. Bader A. Chevalier P. Chauveau J. Zingraff G. Lambrey T.B. Drüeke P. Jungers H. Kreis B. Lacour Serum lipoprotein (a) levels in chronic renal failure and renal transplant patients J Nephrol 7 1994 229 236
94. W.S. Yang S.B. Kim W.K. Min M.S. Lee J.S. Park Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients Nephrol Dial Transplant 10 1995 1668 1671
95. J. Galle J. Bengen P. Schollmeyer C. Wanner Impairment of endothelium-dependent dilation in rabbit arteries by oxidized lipoprotein(a) Circulation 92 1995 1582 1589
96. A. Nguyen C. Lethais J. Zingraff A. Herbelin C. Naret B. Descamps-Latscha Hemodialysis membrane-induced activation of oxydative metabolism detected in vivo and in vitro within microa-mounts of whole blood Kidney Int 28 1986 158 167
97. J.-B. Roullet B. Lacour J.P. Yvert T. Drüeke Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure Am J Physiol 250 1986 E373 E376
98. R.A. DeFronzo J.D. Tobin J.W. Rowe R. Andre Glucose intolerance in uremia J Clin Invest 62 1978 425 435
99. B. Lindholm H.E. Norbeck Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis Acta Med Scand 220 1986 143 151
100. H. Lithell Pathogenesis and prevalence of atherosclerosis in hypertensive patients Am J Hypertens 7 1994 2S 6S
101. J.-P. Després B. Lamarche P. Mauriège B. Cantin G.R. Dagenais S. Moorjani P.-J. Lupien Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
102. I. Giardino D. Edelstein M. Mrwonlee BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advances glycation endproducts in bovine endothelial cells J Clin Invest 97 1996 1422 1428
103. J.W. Heinecke H. Rosen L.A. Suzuki A. Chait The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells J Biol Chem 262 1987 10098 10103
104. G.M. Rodgers T.M. Conn Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells Blood 75 1990 895 901
105. J.-C. Tsai H. Wang M.A. Perella M. Yoshizumi N.E.S. Sibinga L.C. Tan E. Haber T.H.T. Chang R. Schlegel M.-E. Lee Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells J Clin Invest 97 1996 146 153
106. Massy ZA: Moderate hyperhomocyst(c)inemia in renal failure—What are the implications? Nephrol Dial Transplant (in press)
107. P. Chauveau B. Chadefaux M. Coudé J. Aupetit T. Hannedouche P. Kamoun P. Jungers Increased plasma homocysteine concentration in patients with chronic renal failure Miner Electrol Metab 18 1992 196 198
108. B. Hultberg A. Andersson M. Arnadottir Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure Nephron 70 1995 62 67
109. Z.A. Massy B. Chadefaux-Vekemans A. Chevalier C.A. Bader T. Drueke C. Legendre B. Lacour H. Kreis Hyperhomocysteinemia: A significant risk factor for cardiovascular disease in renal transplant recipients Nephrol Dial Transplant 9 1994 1103 1108
110. J. Selhub P.F. Jacques A.G. Bostom R.B. d'Agostino P.W.F. Wilson A.F. Belanger D.H. O'Leary P.A. Wolf E.J. Schaefer I.H. Rosenberg Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis N Engl J Med 332 1995 286 291
111. C.J. Glueck P. Shaw J.E. Lang T. Tracy L. Sieve-Smith Y. Wan Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients Am J Cardiol 75 1995 132 136
112. E. Descombes A.B. Hanck G. Fellay Water-soluble vitamins in chronic hemodialysis patients and need for supplementation Kidney Int 43 1993 1319 1328
113. A.G. Bostom D. Shemin K.L. Lapane A.L. Hume D. Yoburn M.R. Nadeau A. Bendich J. Selhub I.H. Rosenberg High dose-vitamin B treatment of hyperhomocysteinemia in dialysis patients Kidney Int 49 1996 147 152
114. A.B. Haaber I. Eidemak T. Jensen B. Feldt-Rasmussen S. Strandgaard Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure J Am Soc Nephrol 5 1995 1581 1584
115. A.L. Rinehart C.A. Herzog A.J. Collins J.M. Flack J.Z. Ma J.A. Opsahl Greater risk of cardiac events after coronary angioplasty (PICA) than bypass grafting (CABG) in chronic dialysis patients J Am Soc Nephrol 3 1992 389 (abstract)
116. D.S. Milliner A.R. Zinsmeister E. Lieberman B. Landing Soft tissue calcification in pediatric patients with end-stage renal disease Kidney Int 38 1990 931 936
117. J.L. Megnien A. Simon M. Lemariey M.C. Plainfossé J. Levenson Hypertension promotes coronary calcium deposit in asymptomatic men Hypertension 27 1996 949 954
118. M.J. Stampfer C.H. Hennekens J.E. Manson G.A. Colditz B. Rosner W.C. Willett Vitamin E consumption and the risk of coronary disease in women N Engl J Med 328 1993 1444 1449
119. L.H. Kushi A.R. Folsom R.J. Prineas P.J. Mink Y. Wu R.M. Bostick Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women N Engl J Med 334 1996 1156 1162
120. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029 1035
121. N.G. Stephens A. Parsons P.M. Schofield F. Kelly K. Cheeseman M.J. Mitchinson M.J. Brown Randomised controlled trial of vitamin? in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 347 1996 781 786
122. A.M. Lafont Y.C. Chai J.F. Cornhill P.L. Whitlow P.H. Lowe G.M. Chisholm Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis J Clin Invest 95 1995 1018 1025
123. J.T. Salonen K. Salonen M. Seppanen M.R. Kikkas H. Korpela G. Alfthan M. Kantola W. Schalch Effect of antioxidant supplementation on platelet function: A randomized pair-matched, placebo-controlled, double blind trial in men with low antioxidant status Am J Clin Nutr 53 1991 1222 1229
124. R. Faruqi C. Motte P.E. Dicorleto Alpha tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells J Clin Invest 94 1994 592 600
125. N.K. Ozer P. Palozza D. Boscoboinik A. Azzi D-alpha tocopherol inhibits low density lipoprotein adhesion and protein kinase C activity in vascular smooth muscle cells FEBS Lett 322 1993 307 310
126. S. Devaraj D. Li I. Jialal The effects of alpha tocopherol supplementation on monocyte function J Clin Invest 98 1996 756 763
127. M.C. Pastor C. Sierra J. Bonam J. Teixido Serum and erythrocyte tocopherol in uremic patients Am J Nephrol 13 1993 238 243
128. H. Koyama T. Tabata Y. Nishzawa T. Inoue H. Morii T. Yamaji Plasma endothelin levels in patients with uraemia Lancet 1 1989 991 992
129. A.N. Warrens M.J.D. Cassidy K. Takahashi M.A. Ghatei S.R. Bloom Endothelin in renal failure Nephrol Dial Transplant 5 1990 428 422
130. G. Remuzzi D. Marchesi M. Livio A.E. Lavenaghi G. Mecca M.B. Donati G.D. Gaetano Altered platelet and vascular prostaglandin generation in patients with renal failure and prolonged bleeding time Thromb Res 13 1978 1007 1015
131. A. Amore R. Bonaudo D. Ghigo M. Arese C. Costamagna P. Cirina B. Gianoglio L. Perugini R. Coppo Enhanced production of nitric oxide by blood-dialysis membrane interaction J Am Soc Nephrol 6 1995 1278 1283
132. P. Vallance A. Leone A. Calver J. Collier S. Moncada Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
133. H.H. Ting F.K. Timimi K.S. Boles S.J. Creager P. Ganz M.A. Creager Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus J Clin Invest 97 1996 22 28
134. K. Gastaldello A. Vereerstraeten T. Nzame-Nze J.L. Vanherweghem C. Tielemans Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration Nephrol Dial Transplant 10 Suppl 6 1995 44 47
135. A. Pönkä B. Kuhlbäck Serum ascorbic acid in patients undergoing chronic hemodialysis Acta Med Scand 213 1983 305 307
136. M. Nakayama K. Yamada Y. Yamamoto K. Yokoyama H. Nakano H. Kubo T. Shigematsu Y. Kawaguchi O. Sakai Vascular endothelial dysfunction in patients on regular dialysis treatment Clin Nephrol 42 1994 117 120
137. J.C. Gris B. Branger F. Vécina B.A. Sabadani J. Fourcade J.F. Schved Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients Kidney Int 46 1994 807 813
138. J. Nilsson Cytokines and smooth muscle in atherosclerosis Cardiovasc Res 27 1993 1184 1190
139. K. Uyemura L.L. Demer S.C. Castle D. Jullien J.A. Berliner M.K. Gately R.R. Warrier N. Pham A.M. Fogelman R.L. Modlin Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis J Clin Invest 97 1996 2130 2138
140. M.N. Sack D.J. Rader R.O.C. III Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women Lancet 343 1994 269 270
141. E.S. Connolly C.J. Winfree T.A. Springer Y. Naka H. Liao S.D. Yan D.M. Stern R.A. Solomon J.-C. Gutierrez-Ramos D.J. Pinsky Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke J Clin Invest 97 1996 209 216
142. H. Rabb S.J. Agosti P.A. Bittle M. Fernandez G. Ramirez T.F. Tedder Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients J Am Soc Nephrol 6 1995 1445 1450
143. J.L. Melnick E. Adam M.E. Debakey Possible role of cytomegalovirus in atherogenesis JAMA 263 1990 2204 2207
144. M.W. Chang E. Barr M.M. Lu K. Barton J.M. Leiden Adenovirus-meidated over-expression of the cyclinsol;cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neoinitma formation in the rat carotid artery model of balloon angioplasty J Clin Invest 96 1995 2260 2268
145. F.J. Nieto E. Adam P. Sorlie H. Farzadegan J.L. Melnick J.W. Comstock M. Szklo Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis Circulation 94 1996 922 927
146. Y.F. Zhou M.B. Leon M.A. Waclawiw J.F. Popma Z.X. Yu T. Finkel S.E. Epstein Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 335 1996 624 630
147. T.B. Drüeke Z. Abdulmassih B. Lacour C. Bader A. Chevalier H. Kreis Atherosclerosis and lipid disorders after renal transplantation Kidney Int 39 Suppl 31 1991 S24 S28
148. S.E. Roselaar G. Schonfeld A. Daugherty Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity J Clin Invest 96 1995 1389 1394
149. R.H. Grimm A.S. Leon D.B. Hunninghake K. Lenz P. Hannan H. Blackburn Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients Ann Intern Med 94 1981 7 11
150. N. Tanaka S. Sakaguchi K. Oshige T. Niimura T. Kanhisa Effect of chronic administration of propranolol on lipoprotein metablism Metabolism 25 1976 1071 1075
151. J.D. Swales Pharmacological treatment of hypertension Lancet 344 1994 380 385
152. J. Huttunen A. Pasternak T. Vanttinen C. Ehnholm E.A. Nikkila Lipoprotein metablism in patients with chronic uremia. Effect of hemodialysis on serum lipoprotein and post-heparin plasma TG lipases Acta Med Scand 204 1978 211 218
153. H.J. Deuber W. Schulz Reduced lipid concentrations during four years of dialysis with low molecular weight heparin Kidney Int 40 1991 496 500
154. H. Schneider Y. Schmitt Niedermolekulares Heparin: Wie beein-flusst es den Fettstoflwechsel bei chronischen Hamodialysepatienten Klin Wochenschr 69 1991 749 756
155. R.N. Foley P.S. Parfrey J.D. Harnett G.M. Kent D.C. Murray P.E. Barre The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
156. R. Werb W.F. Clark R.M. Lindsay E.O.P. Jones A.L. Linton Serum vitamin A levels and associated abnormalities in patients on regular dialysis treatment Clin Nephrol 12 1979 63 68
157. A. Shaish A. Daugherty F. O'Sullivan G. Schonfeld J.W. Heinicke Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits J Clin Invest 96 1995 2075 2082
158. C.H. Hennekens J.E. Buring J.E. Manson M. Stampfer B. Rosner N.R. Cook C. Belanger F. Lamotte J.M. Gaziano P. Ridker W. Willett R. Peto Lack of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145 1149
159. W.K. Stewart L.W. Fleming Plasma retinol and retinol-binding protein concentration in patients on maintenance hemodialysis with and without vitamin A supplements Nephron 30 1982 15 20
160. G. Stein S. Schone D. Geinitz K. Abendroth F. Kokot R. Fünfstück H. Sperschneider E. Keil No tissue level abnormality of vitamin A concentration despite elevated serum vitamin A of uremic patients Clin Nephrol 25 1986 87 92
161. P.J. Blankestijn Hemodialysis using high flux membranes improves lipid profiles Clin Nephrol 42 Suppl 1 1994 S48 S51
162. G.D. Friedman A.L. Klatsky Is alcohol good for your health N Engl J Med 329 1993 1882 1883
163. E.N. Frankel J. Kanner J.B. German E. Parks J.E. Kinsella Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine Lancet 341 1993 454 457
164. S. Renaud M. Delorgeril Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 339 1992 1523 1526
165. E.B. Rimm A. Klatsky D. Grobbee M.J. Stampfer Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits Br Med J 312 1996 731 736
166. H.O. Hein P. Suadicani F. Gyntelberg Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: Six year follow up in the Copenhagen male study Br Med J 312 1996 736 741
167. G.M. London S.J. Marchais M.E. Safar A.F. Genest A.P. Guérin F. Metivier K. Chedid A.M. London Aortic and large artery compliance in end-stage renal failure Kidney Int 37 1990 137 142
168. M. Barenbrock C. Spieker V. Laske S. Heidenreich H. Hohage J. Bachmann A.P.G. Hoeks K.H. Rahn Studies of the vessel wall properties in hemodialysis patients Kidney Int 45 1994 1397 1400
169. G.M. London A.P. Guerin S.J. Marchais B. Pannier M.E. Safar M. Day F. Metivier Cardiac and arterial interactions in end-stage renal disease Kidney Int 50 1996 600 608
170. V.J. Dzau The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes Curr Opin Nephrol Hypertens 2 1993 27 32
171. A. Kamiya T. Togawa Adaptative regulation of wall shear stress to flow change in the canine carotid artery Am J Physiol 239 1980 H14 H21
172. B.L. Langille F. O'Donnell Reductions in arterial diameters produced by chronic decrease in blood flow are endothelium-dependent Science 231 1986 405 407
173. D.R. Harder Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium Circ Res 60 1987 102 107
174. C.A. Tozzi G.J. Poiani A.M. Harangozo C.D. Boyd D.J. Riley Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium J Clin Invest 84 1989 1005 1012
175. T. Iba T. Shin T. Sonoda O. Rosales B.E. Sumpio Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretch J Surg Res 50 1991 457 460
176. P.F. Davies S.C. Tripathi Mechanical stress mechanisms and the cells: An endothelial paradigm Circ Res 72 1993 239 245
177. R.F. Furchgott J.W. Zawadski The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
178. J.A.E.S. Frangos L.V. McIntire C.L. Ives Flow effects on prostacyclin production by cultured human endothelial cells Science 227 1985 1477 1479
179. + current in vascular endothelial cells Nature 331 1988 168 170
180. J.P. Cooke E. Rossitch Jr. N.A. Andon J. Loscalzo V.J. Dzau Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator J Clin Invest 88 1991 1663 1671
181. X. Girerd G. London P. Boutouyrie J.J. Mourad S. Laurent M. Safar Remodelling of radial artery and chronic increase in shear stress Hypertension 27 part 2 1996 799 803
182. M.J. Roman P.S. Saba R. Pini M. Spitzer T.G. Pickering S. Rosen M.H. Alderman R.B. Devereux Parallel cardiac and vascular adaptation in hypertension Circulation 86 1992 1909 1918
183. P. Boutouyrie S. Laurent X. Girerd A. Benetos P. Lacolley E. Abergel M. Safar Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients Hypertension 25 part 1 1995 651 659
184. P.B. Dobrin F.N. Littooy E.D. Endean Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogeneous vein grafts Surgery 105 1989 393 400
185. S. Laurent X. Girerd J.J. Mourad P. Lacolley L. Beck P. Boutouyrie J.-P. Mignot M. Safar Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension Artenoscler Thromb 14 1994 1223 1231
186. J. Aznar-Salatti G. Escolar A. Cases G. Gomez-Ortiz P. Anton R. Castillo L. Revert A. Ordinas Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix Nephrol Dial Transplant 10 1995 2199 2204
187. 2+ and force generation in resistance arteries Am J Physiol 270 1996 H230 H237
188. J. Atkinson P. Poitevin J.-M. Chillon I. Lartaud B. Levy Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats Am J Physiol 266 1994 H540 H547
189. S.J. Marchais A.P. Guérin B. Pannier B.I. Lévy M.E. Safar G.M. London Wave reflections and cardiac hypertrophy in chronic uremia: Influence of body size Hypertension 22 1993 876 883
190. K. Amann R. Neusüb E. Ritz T. Irzyniec G. Wiest G. Mall Changes of vascular architecture independent of blood pressure in experimental uremia Am J Hypertens 8 1995 409 417
191. G.M. London B. Zins B. Pannier C. Naret J.M. Berthelot C. Jacquot M.E. Safar T.B. Drüeke Vascular changes in hemodialysis patients in response to recombinant human erythropoietin Kidney Int 36 1989 878 882
192. J.S.R.N. Silberberg P.E. Barré A.D. Sniderman Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin Can J Cardiol 6 1990 1 4
193. J.F.E. Mann Hypertension and cardiovascular effects—Long-term safety and potential long-term benefits of r-HuEPO Nephrol Dial Transplant 10 Suppl 2 1995 80 84
194. Z.A. Massy J.Z. Ma T.A. Louis B.L. Kasiske Lipid-lowering therapy in patients with renal disease Kidney Int 48 1995 188 198
195. G.M. London S.J. Marchais A.P. Guérin F. Metivier M.E. Safar F. Fabiani L. Froment Salt and water retention and calcium blockade in uremia Circulation 82 1990 105 113
196. G.M. London B. Pannier A.P. Guérin S.J. Marchais M.E. Safar J.-L. Cuche Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effect of ACE inhibition and calcium channel blockade Circulation 90 1994 2786 2796